Stefan Ivanov

1.6k total citations · 1 hit paper
27 papers, 1.1k citations indexed

About

Stefan Ivanov is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Stefan Ivanov has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Stefan Ivanov's work include Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (7 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Stefan Ivanov is often cited by papers focused on Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (7 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Stefan Ivanov collaborates with scholars based in Sweden, United States and United Kingdom. Stefan Ivanov's co-authors include Anders Lindén, Eric D. Bateman, Helen K. Reddel, J. Mark FitzGerald, Peter J. Barnes, Paul M. O’Byrne, Christina Keen, Rosa Lamarca, Carin Jorup and Nanshan Zhong and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Stefan Ivanov

25 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

2018 366 citations Paul M. O’Byrne, J. Mark FitzGerald et al. profile →

Peers

Countries citing papers authored by Stefan Ivanov

Since Specialization

Citations

This map shows the geographic impact of Stefan Ivanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Ivanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Ivanov more than expected).

Fields of papers citing papers by Stefan Ivanov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Ivanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Ivanov. The network helps show where Stefan Ivanov may publish in the future.

Co-authorship network of co-authors of Stefan Ivanov

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Ivanov. A scholar is included among the top collaborators of Stefan Ivanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Ivanov. Stefan Ivanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety of Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis During the Open-label Extension Period of the Phase 3 MANDARA Study 2024 ·Ulrich Specks, Michael E. Wechsler, David J. Jackson, Florence Roufosse, Allyson Egan, Stefan Ivanov, Maria Jison, (unknown), C. Walton, Peter A. Merkel	1
2	Population Dynamics and Racial and Ethnic Minority Representation in Jury Pools: How Jurisprudence Designed to Reduce Bias can Backfire 2024 ·Race and Social Problems ·Matt Vogel, Stefan Ivanov, (unknown)	0
3	Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·Helen K. Reddel, Paul M. O’Byrne, J. Mark FitzGerald, Peter J. Barnes, Jinping Zheng, Stefan Ivanov, Rosa Lamarca, Margareta Puu, Vijay Alagappan, Eric D. Bateman	18
4	Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies 2021 ·Drug Safety ·J. Mark FitzGerald, Paul M. O’Byrne, Eric D. Bateman, Peter J. Barnes, Jinping Zheng, Stefan Ivanov, Rosa Lamarca, (unknown), (unknown), (unknown), Margareta Puu, Vijay K. T. Alagappan, Filip Surmont, Helen K. Reddel	12
5	Racial Resentment, Empathy, and Support for Release during COVID-19: Results from a Survey Experiment 2021 ·Socius Sociological Research for a Dynamic World ·Stefan Ivanov, Meghan A. Novisky, Matt Vogel	14
6	Selling effective violence prevention policies to the public: a nationally representative framing experiment 2020 ·Journal of Experimental Criminology ·Justin T. Pickett, Stefan Ivanov, Kevin H. Wozniak	10
7	Selling Effective Violence Prevention Policies to the Public: A Nationally Representative Framing Experiment 2020 ·SocArXiv (OSF Preprints) ·Justin T. Pickett, Stefan Ivanov, Kevin H. Wozniak	1
8	Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD 2020 ·Therapeutic Advances in Respiratory Disease ·Wilfried De Backer, Jan De Backer, (unknown), (unknown), Cedric Van Holsbeke, (unknown), Martin Jenkins, (unknown), Stefan Ivanov, Jane Fitzpatrick, Earl St. Rose, Ubaldo J. Martin, Colin Reisner	8
9	Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma 2018 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Paul Rugman, (unknown), Stefan Ivanov, Mohib Uddin	1
10	Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma 2018 ·Drug Design Development and Therapy ·Eric D. Bateman, (unknown), Paul Rugman, (unknown), Stefan Ivanov, Mohib Uddin	22
11	Phenotypes of symptomatic airways disease in China and New Zealand 2017 ·European Respiratory Journal ·James Fingleton, Kewu Huang, Mark Weatherall, Yanfei Guo, Stefan Ivanov, P. L. B. Bruijnzeel, Hong Zhang, Wei Wang, Richard Beasley, Chen Wang	7
12	The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials 2017 ·Trials ·Paul M. O’Byrne, J. Mark FitzGerald, Nanshan Zhong, Eric D. Bateman, Peter J. Barnes, Christina Keen, Gun Almqvist, Kristine Pemberton, Carin Jorup, Stefan Ivanov, Helen K. Reddel	31
13	Whole-Genome Sequencing in Newborn Screening—Attitudes and Opinions of Bulgarian Pediatricians and Geneticists 2017 ·Frontiers in Public Health ·Георги Искров, Stefan Ivanov, (unknown), Румен Стефанов	12
14	Neutralizing Granulocyte/Macrophage Colony–Stimulating Factor Inhibits Cigarette Smoke–induced Lung Inflammation 2010 ·American Journal of Respiratory and Critical Care Medicine ·Ross Vlahos, Steven Bozinovski, (unknown), Stefan Ivanov, Anders Lindén, John A. Hamilton, Gary P. Anderson	94
15	Neutralizing GM-CSF inhibits cigarette smoke-induced lung inflammation 2010 ·Ross Vlahos, Steven Bozinovski, (unknown), (unknown), Stefan Ivanov, Anders Lindén, John A. Hamilton, Gary P. Anderson	3
16	Interleukin-17 as a drug target in human disease 2009 ·Trends in Pharmacological Sciences ·Stefan Ivanov, Anders Lindén	85
17	IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo – effects of anti-inflammatory pharmacotherapy 2008 ·Pulmonary Pharmacology & Therapeutics ·(unknown), Apostolos Bossios, (unknown), Stefan Ivanov, Steven Bozinovski, Ross Vlahos, Margareta Sjöstrand, Gary P. Anderson, Anders Lindén	32
18	Functional Relevance of the IL-23–IL-17 Axis in Lungs In Vivo 2006 ·American Journal of Respiratory Cell and Molecular Biology ·Stefan Ivanov, Steven Bozinovski, Apostolos Bossios, Hadi Valadi, Ross Vlahos, Carina Malmhäll, Margareta Sjöstrand, Jay K. Kolls, Gary P. Anderson, Anders Lindén	60
19	Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust 2005 ·Respiratory Research ·Stefan Ivanov, Lena Palmberg, Per Venge, Kjell Larsson, Anders Lindén	28
20	Interleukin-17 as a Recruitment and Survival Factor for Airway Macrophages in Allergic Airway Inflammation 2005 ·American Journal of Respiratory Cell and Molecular Biology ·Svetlana Sergejeva, Stefan Ivanov, Jan Lötvall, Anders Lindén	141

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact